Using circular RNA to enhance vaccine effectiveness
Circularization of RNA to improve the durability of the vaccine immune response
This study is exploring a new way to make mRNA vaccines work better and last longer by using a special type of RNA, which could help your body remember how to fight off viruses like hantaviruses without needing to get vaccinated as often.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-11131375 on NIH RePORTER |
What this research studies
This research focuses on improving the durability of immune responses generated by mRNA vaccines by utilizing circular RNA technology. Circular RNA has unique properties that allow for prolonged expression and a weaker innate immune response, which may lead to a more effective and lasting antibody response. By mimicking natural antigen delivery kinetics, this approach aims to enhance the body's immune memory and reduce the need for frequent revaccinations. The study specifically targets the immune response to emerging viral infections, such as hantaviruses.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for emerging viral infections, particularly those susceptible to hantaviruses.
Not a fit: Patients who are not at risk for viral infections or those who have already received effective vaccinations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to vaccines that provide longer-lasting immunity, reducing the frequency of vaccinations needed.
How similar studies have performed: Other research has shown promise in using novel RNA technologies to enhance vaccine responses, indicating potential for success in this approach.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Abbott, Robert Koehler — University of Texas Med Br Galveston
- Study coordinator: Abbott, Robert Koehler
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.